{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:34:29Z","timestamp":1790678069967,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009669.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000}}],"reference-count":104,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009669.pub4","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:56:34Z","timestamp":1604602594000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome"],"prefix":"10.1002","volume":"2020","author":[{"given":"Konstantin","family":"Uhlig","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Surgical Intensive Care; Martin-Luther-University Halle-Wittenberg; Halle\/Saale Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljupcho","family":"Efremov","sequence":"additional","affiliation":[{"name":"Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences; Medical School of the Martin-Luther-University Halle-Wittenberg; Halle (Saale) Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Tongers","sequence":"additional","affiliation":[{"name":"Cardiology, Angiology and Intensive Care Medicine; University Hospital Halle (Saale); Halle (Saale) Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frantz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I; University Hospital W\u00fcrzburg; W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mikolajczyk","sequence":"additional","affiliation":[{"name":"Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences; Medical School of the Martin-Luther-University Halle-Wittenberg; Halle (Saale) Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sedding","sequence":"additional","affiliation":[{"name":"Cardiology, Angiology and Intensive Care Medicine; University Hospital Halle (Saale); Halle (Saale) Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schumann","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Surgical Intensive Care; Martin-Luther-University Halle-Wittenberg; Halle\/Saale Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"10.1002\/14651858.CD009669.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amjcard.2006.01.068","article-title":"Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure","volume":"98","author":"Adamopoulos","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0002|cit2","first-page":"338","article-title":"Hemodynamic effects of levosimendan in patients with low cardiac output after cardiac surgery","volume":"59","author":"Alvarez","year":"2006","journal-title":"Revista Espanola de Cardiologia"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0003|cit3","first-page":"63","article-title":"Arrhythmia in patients with low cardiac output after valvular surgery. Randomized, double-blind comparative study of dobutamine versus enoximone","volume":"83","author":"Atallah","year":"1990","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"Spec 3","key":"10.1002\/14651858.CD009669.pub4-BIB0004|cit4","first-page":"57","article-title":"Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery","volume":"83","author":"George","year":"1990","journal-title":"Antagonistes de L'angiotensine II: une Voie Prometteuse"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/jcan.2001.23274","article-title":"Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery","volume":"15","author":"Feneck","year":"2001","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD009669.pub4-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Critical Care Medicine"},{"issue":"SPEC 3","key":"10.1002\/14651858.CD009669.pub4-BIB0008|cit8","first-page":"27","article-title":"A comparison of enoxime and dobutamine in severe chronic congestive cardiac failure with low cardiac output","volume":"83","author":"Galinier","year":"1990","journal-title":"Antagonistes de L'angiotensine II: une Voie Prometteuse"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ejheart.2006.01.007","article-title":"Cardiogenic shock after primary percutaneous coronary intervention: effects of levosimendan compared with dobutamine on haemodynamics","volume":"8","author":"Garc\u00eda-Gonz\u00e1lez","year":"2006","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijcard.2007.04.143","article-title":"Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty","volume":"127","author":"Samini-Fard","year":"2008","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/eurjhf\/hfs215","article-title":"Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study","volume":"15","author":"Husebye","year":"2013","journal-title":"European Journal of Heart Failure"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0012|cit12","first-page":"289","article-title":"Comparison of enoximone versus tobutamine in the treatment of low cardiac output after cardiac surgery","volume":"9","author":"Lancon","year":"1990","journal-title":"Annales Francaises d'Anesthesie et de Animation"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1157\/13119990","article-title":"The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome","volume":"61","author":"Levin","year":"2008","journal-title":"Revista Espa\u0148ola de Cardiolog\u00eda"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"Levy","year":"2011","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009669.pub4-BIB0016|cit16","first-page":"13","article-title":"CO-65 Comparison of epinephrine and norepinephrine for the treatment of cardiogenic shock following acute myocardial infarction. OPTIMA CC study","volume":"8","author":"Levy","year":"2018","journal-title":"Annals of Intensive Care"},{"issue":"17","key":"10.1002\/14651858.CD009669.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD009669.pub4-BIB0018|cit18","first-page":"839","article-title":"Differential therapy of cardiogenic shock with dopamine\/milrinone in comparison with dopamine\/dobutamine","volume":"85","author":"Meissner","year":"1996","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"6","key":"10.1002\/14651858.CD009669.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/bja\/71.6.869","article-title":"Comparison of the haemodynamic effects of enoximone and piroximone in patients after cardiac surgery","volume":"71","author":"Patel","year":"1993","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s001340050439","article-title":"Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine?","volume":"23","author":"Rosseel","year":"1997","journal-title":"Intensive Care Medicine"},{"issue":"18","key":"10.1002\/14651858.CD009669.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","article-title":"Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure","volume":"102","author":"Slawsky","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/clc.4960180308","article-title":"Enoximone versus epinephrine\/nitroglycerin in cardiac low-output states following valve replacement","volume":"18","author":"Zwolfer","year":"1995","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.jvca.2006.02.012","article-title":"Levosimendan or milrinone in the type 2 diabetes patient with low ejection fraction undergoing elective coronary artery surgery","volume":"20","author":"Al-Shawaf","year":"2006","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/1053-0770(92)90096-P","article-title":"Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery","volume":"6","author":"Dupuis","year":"1992","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"11","key":"10.1002\/14651858.CD009669.pub4-BIB0025|cit25","first-page":"563","article-title":"Inotropic therapy for cardiac low output syndrome","volume":"12","author":"Arlt","year":"2007","journal-title":"European Journal of Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0026|cit26","first-page":"77","article-title":"Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery","volume":"24","author":"Pomer","year":"1986","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0027|cit27","first-page":"135","article-title":"Nitroglycerin and dobutamine in the treatment of low cardiac output syndrome after direct myocardial revascularization","volume":"40","author":"Rychter","year":"1985","journal-title":"Wplyw Glukagonu na Uklad Krazenia"},{"issue":"9","key":"10.1002\/14651858.CD009669.pub4-BIB0028|cit28","first-page":"1490","article-title":"Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan","volume":"24","author":"Seino","year":"1996","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0029|cit29","unstructured":"Milrinone versus dobutamine in critically ill patients clinicaltrials.gov\/show\/NCT03207165"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0030|cit30","unstructured":"Norepinephrine vs norepinephrine and dobutamine in cardiogenic shock clinicaltrials.gov\/show\/NCT03340779"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0031|cit31","unstructured":"Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock clinicaltrials.gov\/show\/NCT04020263"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0032|cit32","first-page":"1275-359","volume-title":"Hurst\u2019s The Heart","author":"Alexander","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of\u00a0Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bja\/aev284","article-title":"The effect of inotropes and vasopressors on mortality","volume":"115","author":"Belletti","year":"2015","journal-title":"British Journal of Anaesthesia"},{"issue":"10","key":"10.1002\/14651858.CD009669.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics: 2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0036|cit36","unstructured":"Centers for Disease Control and Prevention. Heart Disease and Stroke Prevention www.cdc.gov\/chronicdisease\/resources\/publications\/aag.htm"},{"issue":"8","key":"10.1002\/14651858.CD009669.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"Chioncel","year":"2020","journal-title":"European Journal of Heart Failure"},{"issue":"385","key":"10.1002\/14651858.CD009669.pub4-BIB0038|cit38","first-page":"1","article-title":"Levosimendan in the light of the results of the recent randomized controlled trials. An expert opinion paper","volume":"23","author":"Cholley","year":"2019","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2008.08.020","article-title":"Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials","volume":"138","author":"Delaney","year":"2010","journal-title":"International Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD009669.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1223-5","DOI":"10.1161\/01.CIR.0000121424.76486.20","article-title":"Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction - every minute of delay counts","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD009669.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ejhf.339","article-title":"Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes","volume":"17","author":"De Luca","year":"2015","journal-title":"European Journal of Heart Failure"},{"issue":"11","key":"10.1002\/14651858.CD009669.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00134-009-1591-4","article-title":"Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure","volume":"35","author":"Den Uil","year":"2009","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Den Uil CA Lagrand WK Van der Ent M Nieman K Struijs A Jewbali LSD Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock PLOS\u00a0One 2014 9 8 e103978","DOI":"10.1371\/journal.pone.0103978"},{"issue":"7","key":"10.1002\/14651858.CD009669.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4244\/EIJ-D-19-00254","article-title":"Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial","volume":"15","author":"Den Uil","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Elbadawi A Elgendy IY Mahmoud K Barakat AF Mentias A Mohamed AH Temporal trends and outcomes of mechanical complications in patients with acute myocardial infarction Journal of the American College of Cardiology, Cardiovascular Interventions 2019 12 18 1825-36","DOI":"10.1016\/j.jcin.2019.04.039"},{"issue":"7","key":"10.1002\/14651858.CD009669.pub4-BIB0046|cit46","first-page":"409","article-title":"Levosimendan in patients with cardiogenic shock complicating myocardial infarction","volume":"42","author":"Fang","year":"2018","journal-title":"Medicina\u00a0Intensiva"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003709.pub4","article-title":"Vasopressors for hypotensive shock","author":"Gamper","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0048|cit48","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009669.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009669.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009669.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009669.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD009669.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijcard.2009.05.058","article-title":"The type of acute heart failure and the costs of hospitalization","volume":"145","author":"Harjola","year":"2010","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD009669.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.jvca.2013.03.027","article-title":"Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis","volume":"27","author":"Harrison","year":"2013","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0058|cit58","first-page":"122","article-title":"National average costs by department for heart failure and shock","volume":"64","author":"Healthcare Financial Management Association","year":"2010","journal-title":"Healthcare Financial Management"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0060|cit60","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularisation in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD009669.pub4-BIB0062|cit62","first-page":"2998-3002","article-title":"Cardiogenic shock complicating acute myocardial infarction - expanding the paradigm","volume":"107","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10741-007-9017-2","article-title":"Vasodilators in acute heart failure","volume":"12","author":"Hollenberg","year":"2007","journal-title":"Heart Failure Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.trsl.2010.07.011","article-title":"Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock","volume":"156","author":"How","year":"2010","journal-title":"Translational Research"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1631\/jzus.B1200290","article-title":"Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials","volume":"14","author":"Huang","year":"2013","journal-title":"Journal of Zhejiang University - SCIENCE B"},{"issue":"9","key":"10.1002\/14651858.CD009669.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009669.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"e2051","DOI":"10.3390\/jcm9072051","article-title":"Vasopressors and inotropes in acute myocardial infarction related cardiogenic shock: a systematic review and meta-analysis","volume":"9","author":"Karami","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00134-014-3604-1","article-title":"Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis","volume":"41","author":"Koster","year":"2015","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009669.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2009.05.031","article-title":"Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials","volume":"24","author":"Landoni","year":"2010","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0070|cit70","first-page":"276","article-title":"Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies","volume":"76","author":"Landoni","year":"2010","journal-title":"Minerva Anestesiologica"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","article-title":"Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies","volume":"40","author":"Landoni","year":"2012","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0072|cit72","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD009669.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients","volume":"44","author":"Leopold","year":"2018","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/cc10263","article-title":"Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials","volume":"15","author":"Maharaj","year":"2011","journal-title":"Critical Care"},{"issue":"7","key":"10.1002\/14651858.CD009669.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: Heart disease and stroke statistics - 2016 Update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD009669.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/HCO.0000000000000057","article-title":"Pharmacologic therapies for acute cardiogenic shock","volume":"29","author":"Nativi-Nicolau","year":"2014","journal-title":"Current Opinion in Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2014.04.111","article-title":"Repetitive use of levosimendan for treatment of chronic advanced heart failure","volume":"174","author":"Nieminen","year":"2014","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"150-7","DOI":"10.1016\/j.ijcard.2016.05.009","article-title":"The role of levosimendan in acute heart failure complicating acute coronary syndrome: a review and expert consensus opinion","volume":"218","author":"Nieminen","year":"2016","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0080|cit80","first-page":"e362-e425","article-title":"2013 ACCF\/AHA Guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD009669.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1016\/j.ejmech.2010.08.001","article-title":"Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cells","volume":"45","author":"Pietrangelo","year":"2010","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1002\/14651858.CD009669.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"891-975","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"18","author":"Ponikowski","year":"2016","journal-title":"European Journal of Heart Failure"},{"issue":"8","key":"10.1002\/14651858.CD009669.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrcardio.2016.96","article-title":"Management of refractory cardiogenic shock","volume":"13","author":"Reyentovich","year":"2016","journal-title":"Nature Reviews Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD009669.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock - current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1590\/S0066-782X2010005000072","article-title":"Levosimendan in acute decompensated heart failure: systematic review and meta-analysis","volume":"95","author":"Ribeiro","year":"2010","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"1","key":"10.1002\/14651858.CD009669.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/157489011794578455","article-title":"Levosimendan: from basic science to clinical trials","volume":"6","author":"Rognoni","year":"2011","journal-title":"Recent Patents on Cardiovascular Drug Discovery"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0087|cit87","first-page":"20","article-title":"Heterogeneity in meta-analysis: misconceiving I2","volume":"Suppl VI","author":"R\u00fccker","year":"2008","journal-title":"Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"},{"issue":"2","key":"10.1002\/14651858.CD009669.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2007.04.143","article-title":"Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty","volume":"127","author":"Samimi-Fard","year":"2008","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0089|cit89","doi-asserted-by":"crossref","unstructured":"Knight JB \u00a0Santonocito C \u00a0Pastore F \u00a0Lorini FL Levosimendan for patients with severely reduced left ventricular systolic function and\/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis Critical Care 2017 21 1 252","DOI":"10.1186\/s13054-017-1849-0"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0090|cit90","first-page":"28","article-title":"Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments","volume":"74","author":"Santesso","year":"2016","journal-title":"Journal of\u00a0Clinical\u00a0Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD009669.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","article-title":"AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews","volume":"62","author":"Shea","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD009669.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00392-013-0649-z","article-title":"Intermittent levosimendan improves mid-term survival in chronic heart failure patients","volume":"103","author":"Silvetti","year":"2014","journal-title":"Clinical Research in Cardiology"},{"issue":"18","key":"10.1002\/14651858.CD009669.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1752-8","DOI":"10.1016\/j.jacc.2007.04.101","article-title":"Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock","volume":"50","author":"Singh","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1002\/14651858.CD009669.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/eurheartj\/ehs289","article-title":"Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry","volume":"33","author":"Steg","year":"2012","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD009669.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1388-9842(02)00041-7","article-title":"The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis","volume":"4","author":"Thackray","year":"2002","journal-title":"European Journal of Heart Failure"},{"issue":"32","key":"10.1002\/14651858.CD009669.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"European Heart Journal"},{"issue":"19","key":"10.1002\/14651858.CD009669.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0098|cit98","doi-asserted-by":"crossref","unstructured":"Werdan K Ru\u00df M Boeken U Buerke M Briegel J Delle-Karth G Deutsch-\u00f6sterreichische S3 Leitlinie \u201eInfarktbedingter kardiogener Schock - Diagnose, Monitoring und Therapie\u201c leitlinien.dgk.org\/2020\/deutsch-oesterreichische-s3-leitlinie-infarktbedingter-kardiogener-schock-diagnose-monitoring-und-therapie\/","DOI":"10.1007\/s12181-020-00419-8"},{"issue":"9892","key":"10.1002\/14651858.CD009669.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"644-57","DOI":"10.1016\/S0140-6736(13)61452-X","article-title":"Future treatment strategies in ST-segment elevation myocardial infarction","volume":"382","author":"Windecker","year":"2013","journal-title":"Lancet"},{"issue":"23","key":"10.1002\/14651858.CD009669.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2155-65","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009669.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"1-3","key":"10.1002\/14651858.CD009669.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejphar.2009.06.021","article-title":"Milrinone inhibits hypoxia or hydrogen dioxide-induced persistent sodium current in ventricular myocytes","volume":"616","author":"Zheng","year":"2009","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD009669.pub4-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009669.pub3","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","author":"Schumann","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009669.pub4-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009669.pub2","article-title":"Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome","author":"Unverzagt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T04:05:03Z","timestamp":1687233903000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009669.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":104,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009669.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}